Blood test to find early return of endometrial or cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether a blood test can find cancer returning earlier than usual scans, in people who had endometrial or cervical cancer. If you've finished or are on standard treatment, your blood may help show if the cancer comes back sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have endometrial cancer or cervical cancer confirmed by biopsy.
- You are scheduled for or have completed standard treatment like surgery, chemotherapy, or radiation.
- You agree to give blood samples for this research.
- You do not have another active cancer that needs treatment now.
- You are able to attend follow-up visits.
- You do not have bleeding problems or an infection that makes blood draws unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether simple blood tests can help predict how well first-line treatment works for cervical cancer that has come back or spread. It aims to improve future care by tracking changes in the blood over time.
This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.
This trial uses a special blood test to look for tumor DNA in your blood to monitor for cervical cancer recurrence and help guide treatment decisions. It may help your doctor know if your cancer is coming back and choose the best treatment options.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This observational study checks whether a blood test (a “cfDNA” test) can detect early signs of cancer or small amounts of cancer left after treatment. It may help doctors use a simple blood sample to improve cancer detection and follow-up.
This trial uses a blood test to find early signs of cancer or leftover tumor cells after treatment. It may help people with certain cancers or those with non-cancerous growths understand their condition better.
Hear when a new Uterine Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.